BioSpace News Archive

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office (USPTO).

Madrigal Pharmaceuticals, Inc. announced today its management team will participate in two upcoming virtual investor conferences: Evercore ISI 4th Annual HealthCONx Conference 2021 Fireside chat at 9:40 AM EST on Tuesday, November 30, 2021.

Tonix Pharmaceuticals Holding Corp. today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) Application to support the initiation of a Phase 2 study of TNX-1900* (intranasal potentiated oxytocin) for the prevention of migraine headache in chronic migraineurs.

XORTX Therapeutics Inc. announces that it will hold its annual and special meeting of shareholders at 11:00 a.m. (Calgary time) on Monday, December 20, 2021.

Oncotelic Therapeutics, Inc. today announced that its COVID-19 trial (“C001”) for OT-101 has successfully met its safety and efficacy endpoints.

Vipergen announced today the signing of a multi-target drug discovery agreement with Aligos Therapeutics, Inc. (Nasdaq: ALGS).

Study conducted and costs covered by Vetbiolix, Can-Fite’s development and commercialization partner for the veterinary market.

Bristol Myers Squibb Receives European Commission Approval of Zeposia (ozanimod) for use in Adults with Moderately to Severely Active Ulcerative Colitis.

Dante Labs today announced its Black Friday offer for whole genome sequencing test and interpretation at 50% off its already unbeatable list price, plus free worldwide shipping.

Oncotelic Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2021 (“ Q3 202 1 ”), as well as an update on its product and therapeutic development initiatives and other corporate updates.